(Q39477514)

English

Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Knockdown of RON inhibits AP-1 activity and induces apoptosis and cell cycle arrest through the modulation of Akt/FoxO signaling in human colorectal cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

apoptotic process

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Cho-Yun Chung

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Young-Lan Park

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Young-A Song

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Eun Myung

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kyu-Yeol Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Gi-Hoon Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ho-Seok Ki

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kang-Jin Park

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sung-Bum Cho

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Wan-Sik Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Young-Do Jung

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kyung-Keun Kim

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Young-Eun Joo

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

8 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

371-380

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Ron-receptor tyrosine kinase in tumorigenesis and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

RON, a tyrosine kinase receptor involved in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Oncogenic signaling pathways activated by RON receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Overexpression of the RON gene in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Macrophage-stimulating protein and its receptor in non-small-cell lung tumors: induction of receptor tyrosine phosphorylation and cell migration

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

AP-1 a target for cancer prevention

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise?

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Transcription factors control invasion: AP-1 the first among equals

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

A new fork for clinical application: targeting forkhead transcription factors in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

The role of Forkhead-box Class O (FoxO) transcription factors in cancer: a target for the management of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

FOXO transcription factors: key regulators of cell fate

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Colon carcinogenesis: Learning from NF-kappaB and AP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Social controls on cell survival and cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Cell metabolism: an essential link between cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

The activation of Akt/PKB signaling pathway and cell survival.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Small-molecule inhibitors of the PI3K signaling network

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

FoxO1: a molecule for all seasons

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Sense and sensitivity: FOXO and ROS in cancer development and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Adding more content to screening: reactivation of FOXO as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

The "O" class: crafting clinical care with FoxO transcription factors

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1892-7

21 January 2018

Monoclonal antibody (mAb)-induced down-regulation of RON receptor tyrosine kinase diminishes tumorigenic activities of colon cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901254

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21901254

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-011-1892-7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39477514&oldid=2202915347"